KIDNEY  TRANSPLANTATION  STUDIES

OPEN ENROLLMENT

Mercury- Living Donor Kidney Tx (with Bone Marrow) 

A Phase 3 Prospective, Randomized, Multi-center, Open-label, Controlled Trial to Assess the Efficacy and Safety of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-matched, Living Donor Kidney Transplants

Funded by Medeor Therapeutics, Inc

OPEN ENROLLMENT

A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of CINRYZE® (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients. 

Funded by Shire ViroPharma, Inc.. 

OPEN ENROLLMENT

A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis (FSGS) in de novo Kidney Transplant Recipients.

Funded by Astellas Pharma Global Development, Inc.

COMPLETED

A Phase 2a, Randomized, Open-Label, Active Control, Multi- Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients

Funded by Astellas Pharma Global Development, Inc.

COMPLETED

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor.

 

Funded by Astellas Pharma Global Development, Inc. 

KONTAKT 

 

 

Polsko-Amerykanskie Centrum Transplantologii

 

Instytut Transplantologii

University of Chicago 

5841 S. Maryland Avenue

MC 5026, J-517

Chicago IL 60637

 

tel. (773) 834-8482

Patrycja.Ulijaszyk@uchospitals.edu

CONTACT

 

 

Polish-American Transplant Center

 

Transplant Institute

University of Chicago Medicine

5841 S. Maryland Avenue

MC 5026, J-517

Chicago IL 60637

 

tel. (773) 834-8482

Patrycja.Ulijaszyk@uchospitals.edu

© 2018 by Kajetan Witkowski